Monday Morning Reads

Good morning, hopefully you had a great weekend and perhaps were lucky enough to have an extended weekend.  Here is what I am reading as we start the work week:

  • Biogen and Eisai released data from their Alzheimer clinical trial last week and the market responded very positively, but are the results really what they seem (Forbes)?
  • The week ahead in biotech, a roundup of conferences, PDUFA dates and Clinical Trials (Benzinga).
  • Medtech investing advice from the trenches (Medical Design & Outsourcing).
  • According to Deloitte’s second annual real-world evidence benchmarking survery, biopharma is embracing real-world evidence (BioPharma Dive).

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s